Riskpilot← Back to searchSign inGet full accessEVIDENCEBASED TECHNOLOGY AS
ASActiveOrg 921995644Skiringssalveien 20, 3208 SandefjordOther human health activities n.e.c. · NACE 8699Est. 20190 employees
Revenue 2024
NOK 10K
0% vs 2023
EBITDA margin
-1748.7%
-2% vs 2023
Equity ratio
93.1%
Financial strength
Net profit 2024
NOK -190K
+69% vs 2023
| Revenue | NOK 10K | +0% |
| EBITDA | NOK -178K | -2% |
| Net profit | NOK -190K | +69% |
| Total assets | NOK 2,2M | -9% |
| Equity | NOK 2M | -9% |
| Employees | 0 | — |
Legal name
EVIDENCEBASED TECHNOLOGY AS
Org number
921995644
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
8. januar 2019
Share capital
NOK 2 014 770
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Investeringer i selskaper, utvikling og drift av helserelatert behandling samt det som naturlig står i forbindelse med dette direkte eller ved deltakelse i andre selskaper.
Address
Skiringssalveien 20, 3208 Sandefjord
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 139 | 10 | 10 | 10 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 0 | −27 | −54 | −639 | −176 | −175 | −178 |
| Depreciation & amort. | −0 | −0 | −0 | −7 | −12 | −12 | −12 |
| EBIT | 0 | −27 | −54 | −646 | −188 | −187 | −190 |
| Net financials | 0 | 0 | 37 | −0 | 0 | −435 | 0 |
| Profit before tax | 0 | −27 | −17 | −646 | −188 | −623 | −190 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | 0 | −27 | −17 | −646 | −188 | −623 | −190 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | 1 000 | 1 631 | 2 541 | 2 946 | 2 661 | 2 358 | 2 154 |
| Equity | 988 | 1 461 | 2 520 | 2 632 | 2 444 | 2 195 | 2 005 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 135 |
| Short-term debt | 12 | 170 | 20 | 314 | 217 | 163 | 14 |
| Total debt | 12 | 170 | 20 | 314 | 217 | 163 | 149 |
EBITDA margin
-1748.7%
This company
15.8%
Market median
-11168% vs market
20182024
Equity ratio
93.1%
This company
38.2%
Market median
+144% vs market
20182024
Return on equity
-9.5%
This company
18.4%
Market median
-152% vs market
20182024
Net profit margin
-1865.7%
This company
8.1%
Market median
-23133% vs market
20182024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20182024
Debt / equity
0.07×
This company
0.62×
Market median
+89% vs market
20182024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-12-06 – 2018-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2021 | — | — | |
| Chairman | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Rorom As | Company | 18.5% | 18.5% | 2022 |
| Individual | 15.1% | 15.1% | 2022 | |
Eurodoc As | Company | 14.7% | 14.7% | 2022 |
Traveldoktor As | Company | 14.3% | 14.3% | 2022 |
Sandefjord Helsepark Legene Syd As | Company | 13.4% | 13.4% | 2022 |
Sportstek As | Company | 11.3% | 11.3% | 2022 |
4x4 Medex As | Company | 3.3% | 3.3% | 2022 |
| Individual | 2.7% | 2.7% | 2022 | |
Evidencebased Technology As | Company | 2.6% | 2.6% | 2022 |
Ballke Invest As | Company | 2.3% | 2.3% | 2022 |
| Individual | 1.8% | 1.8% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Traveldoktor As
EVIDENCEBASED TECHNOLOGY AS Board members of EVIDENCEBASED TECHNOLOGY AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tom Dahl Frøshaug | Board of Directors | 0 companies |
| Jo Kristoffer Bergsvand | Board of Directors | 0 companies |
| Hans Jacob Gravdal | Board of Directors | 0 companies |
| Hans Erik Tofte | Chairman | 0 companies |
| Nils Kähler | Board of Directors | 0 companies |
| Kristin Henden | Board of Directors | 0 companies |
| Per Thomas Mørk | Board of Directors | 0 companies |